Events

Annual Dinner 2012
Mon, 23 Jan 2012

News

Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis  
Mon, 11 Apr 2011

LUND, SWEDEN--(Marketwire - April 11, 2011) - Teva Pharmaceutical Industries Ltd. (NASDAQ:

Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710  
Sun, 10 Apr 2011

WHITEHOUSE STATION, N.J., and VIENNA, April 11, 2011 /PRNewswire/ -- Mer...

Join BAPA re-new
MEMBER LOGIN
User Name:
Password:

Forgot Password?

Sign up for e-Newsletter